Lord, Abbett & Co »

Nektar Therapeutics shares owned by Lord, Abbett & Co

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Lord, Abbett & Co from 13F filings

Historical chart of Lord, Abbett & Co investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Lord, Abbett & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Lord, Abbett & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $29M 405k 71.95

More positions owned by Lord, Abbett & Co

NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Apple (AAPL)
Microsoft Corporation (MSFT)
JPMorgan Chase & Co. (JPM)
Taiwan Semiconductor Mfg (TSM)
Exxon Mobil Corporation (XOM)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
Morgan Stanley (MS)
Parker-Hannifin Corporation (PH)
Amazon (AMZN)
Lam Research (LRCX)
Entergy Corporation (ETR)

View all positions for Lord, Abbett & Co

Top funds holding Nektar Therapeutics

BVF
Two Seas Capital
Vanguard Capital Management
Susquehanna International
Vanguard Group
Two Sigma Investments
BlackRock
Citadel Advisors
Morgan Stanley
Armistice Capital
Invesco
Prosight Management
Sofinnova Ventures
Woodline Partners
Lord, Abbett & Co

View all funds holding Nektar Therapeutics